2021.04.06 复盘笔记 by 垃圾股战斗鸡儿

2021-04-06

2021-04-06	成本	现价	浮动收益
Histogenics Corporation(OCGN)	0.5338	6.35	+1,091.49%

I think Covaxin is very difficult to get fda eua approach to USA before May.The important case is the phase 3 hasn't U.S clinical trials. so I just sell off the last position.

晒晒我的复盘笔记

交易复盘是每个投资者的必修课，分享复盘笔记，可以帮助我们更好的修正自己的交易行为。小虎君想邀请广大虎友阶段性的复盘自己的交易，总结自己的交易得失。欢迎大家积极参与！

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":343206781,"tweetId":"343206781","gmtCreate":1617716982343,"gmtModify":1617716982343,"author":{"id":3463341005279592,"idStr":"3463341005279592","authorId":3463341005279592,"authorIdStr":"3463341005279592","name":"徐州垃圾股战斗机","avatar":"https://static.tigerbbs.com/6e4f5025873234ad12c3bc45049e174a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":97,"starInvestorFlag":false},"themes":[{"themeId":"f3d87ca4ae5443109e3e2bba23b4a25c","categoryId":"b76d3c59fc044df59779c041b25852a6","name":"晒晒我的复盘笔记","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":f3d87ca4ae5443109e3e2bba23b4a25c}&rnconfig={\"headerBarHidden\": true}","description":"交易复盘是每个投资者的必修课，分享复盘笔记，可以帮助我们更好的修正自己的交易行为。小虎君想邀请广大虎友阶段性的复盘自己的交易，总结自己的交易得失。欢迎大家积极参与！","image":"https://static.tigerbbs.com/00be65364555c13911c6d14681ef1b80"}],"images":[],"coverImages":[],"title":"2021.04.06 复盘笔记 by 垃圾股战斗鸡儿","extraTitle":"","html":"<html><head></head><body><section class=\"trade-note\">\n <table class=\"note-table\" contenteditable=\"false\">\n  <tbody>\n   <tr class=\"tr1\">\n    <td class=\"col1\"><span class=\"tip\">2021-04-06</span></td>\n    <td class=\"col2\">成本</td>\n    <td class=\"col3\">现价</td>\n    <td class=\"col4\">浮动收益</td>\n   </tr>\n   <tr class=\"tr2\">\n    <td class=\"col1\">Histogenics Corporation(OCGN)</td>\n    <td class=\"col2\">0.5338</td>\n    <td class=\"col3\">6.35</td>\n    <td class=\"col4 increase\">+1,091.49%</td>\n   </tr>\n  </tbody>\n </table>\n</section><p>I think&nbsp;Covaxin is very difficult to get fda eua approach to USA before May.The important case is the phase 3 hasn't U.S clinical trials.&nbsp;so I just sell off the last position.</p></body></html>","htmlText":"<html><head></head><body><section class=\"trade-note\">\n <table class=\"note-table\" contenteditable=\"false\">\n  <tbody>\n   <tr class=\"tr1\">\n    <td class=\"col1\"><span class=\"tip\">2021-04-06</span></td>\n    <td class=\"col2\">成本</td>\n    <td class=\"col3\">现价</td>\n    <td class=\"col4\">浮动收益</td>\n   </tr>\n   <tr class=\"tr2\">\n    <td class=\"col1\">Histogenics Corporation(OCGN)</td>\n    <td class=\"col2\">0.5338</td>\n    <td class=\"col3\">6.35</td>\n    <td class=\"col4 increase\">+1,091.49%</td>\n   </tr>\n  </tbody>\n </table>\n</section><p>I think&nbsp;Covaxin is very difficult to get fda eua approach to USA before May.The important case is the phase 3 hasn't U.S clinical trials.&nbsp;so I just sell off the last position.</p></body></html>","text":"2021-04-06 成本 现价 浮动收益 Histogenics Corporation(OCGN) 0.5338 6.35 +1,091.49% I think Covaxin is very difficult to get fda eua approach to USA before May.The important case is the phase 3 hasn't U.S clinical trials. so I just sell off the last position.","highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/343206781","repostId":0,"isVote":1,"tweetType":1,"viewCount":2561,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["OCGN"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":217,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/343206781"}